Clinical Trial Update: Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

View source ↗

Summary

This clinical trial update describes a retrospective observational study comparing the cost-effectiveness of adding sulfonylureas versus DPP-4 inhibitors to met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Glimepiride (glimepiride)
• Glipizide (Glipizide)
• Glyburide (glibenclamide) (glibenclamide)
• Linagliptin (linagliptin)
• Saxagliptin (saxagliptin)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin | Status: RECRUITING